Cite

HARVARD Citation

    Statler, V. et al. (2019). Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6–59 months of age: A phase 3, randomized, noninferiority study. Vaccine. 37 (2), pp. 343-351. [Online]. 
  
Back to record